To investigate the clinical impact of the two regulators, RHEB, and EIF5, of mTOR signaling in hepatitis B-related HCC, we evaluated the association of the two proteins with the clinicopathological parameters, which was summarized in Table 1. This evidence concerns the gene EIF5 and hepatitis B virus infection.